United States

Securities and Exchange Commission

Washington, DC 20549

 

 

Form 8-K/A

 

 

Amendment No. 1 to Current Report

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

 

Date of Report: May 4, 2012

 

GeneLink, Inc.

 

(Exact Name of Registrant as Specified in its Charter)

 

 

PA   00-30518   23-2795613

(State or other

Jurisdiction of

Incorporation)

  (Commission File Number)  

(IRS Employer
Identification No.)

 

 

8240 Exchange Dr. Suite C1, Orlando, FL 32809

(Address of Principal Executive Offices)

 

Registrant’s telephone number, including area code: (800) 558-4363

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

1
 

EXPLANATORY NOTE

 

GeneLink, Inc. (the “Company”) is filing this Current Report on Form 8-K/A as Amendment No. 1 to its Current Report on Form 8-K on May 10, 2012 to include the Company’s earning’s release in its Item 2.02 disclosure and to disclose the details of restatements to the Company’s audited consolidated financial statements for the year ended December 31, 2010 and the Company’s unaudited consolidated financial statements contained within the Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2010, June 30, 2010, September 30, 2010, March 31, 2011, June 30, 2011, and September 30, 2011 in its Item 4.02 disclosure. No other information contained in the Form 8-K is amended by this Form 8-K/A.

 

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

 

On May 10, 2012, GeneLink, Inc. (the “Company”) issued a press release reporting its financial results for the year ended December 31, 2011 and the re-audit and restatement for the year ended December 31, 2010 (the “Earnings Release”). The Earnings Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, and shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended.

 

 

ITEM 4.02 NON-RELIANCE ON PREVIOUSLY ISSUED FINANCIAL STATEMENTS OR A RELATED AUDIT REPORT OR COMPLETED INTERIM REVIEW.

 

On May 4, 2012, the Board of Directors of GeneLink, Inc. (the “Company”), upon the recommendation of management after consulting with its independent auditors, concluded that the Company’s financial statements for the year ended December 31, 2010 and the Company’s unaudited consolidated financial statements contained within the Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2010, June 30, 2010, September 30, 2010, March 31, 2011, June 30, 2011, and September 30, 2011 could no longer be relied upon. The Company intends to file its restated financial statements for the year ended December 31, 2010 in conjunction with the filing of the Company’s Annual Report on Form 10-K for the year ended December 31, 2011, which which is expected to be filed on Monday, May 14, 2012.

 

A re-audit of 2010 was required when, on March 5, 2012, the Company was notified that the Public Company Accounting Oversight Board (“PCAOB”) announced that it had suspended for one year the registration of Buckno Lisicky & Company, P.C. (“Buckno”). Buckno, the company’s prior independent registered accountants, was suspended for failure to timely file 2010 and 2011 annual reports with the PCAOB. As a result of that suspension, the SEC determined that the Company could no longer include the audit reports of Buckno in its SEC filings. A re-audit by a new firm was required to address 2010 comparative figures included in the 2011 Form 10-K filing.

 

The Company’s financial statements for the year ended December 31, 2010 will be restated to reflect the following:

 

2
 

The valuation of warrants and a beneficial conversion feature related to convertible debt issued in 2009 had been improperly calculated. The beneficial conversion feature (“BCF”) originally recorded was $150,000 but did not consider the fair value of the debt. As a result, the BCF should have been $406,395, an understatement of the BCF debt discount and additional paid-in capital of $256,395. In addition, warrants valued at $132,800 issued to the placement agent in connection with the convertible debt were improperly recorded as a reduction of additional paid-in capital versus loan costs. The Company determined that the amortization of the loan costs, warrant discount and BCF discount related to the convertible debt was improperly recorded and interest expense was understated by $83,491

 

In addition, the Company determined that certain prepaid balances at December 31, 2010 totaling $95,742 were overstated of which $80,000, net of accumulated depreciation of $29,000, should have been recorded as equipment. In addition, accounts payable and accrued expenses (excluding accrued compensation) were understated by $55,032. As a result, cost of sales, general and administrative expense and depreciation expense were understated by $18,615, $52,160 and 29,000, respectively. The Company also determined that intangible assets related to patents were overstated by $38,474 as of December 31, 2010, and amortization expense for 2010 was understated by $4,783.

 

In addition to the items noted above, the Company determined that certain reclassifications were required to correctly present its 2010 financial statements. These reclassifications included reclassifying accounts receivable of $99,000 to deferred revenue since both amounts were related to transactions with the same company and management determined right of offset existed. The Company also reclassified its insurance accrual of $27,504 from current maturity of long term-debt and reclassified this balance as a reduction of the related prepaid insurance balance.

 

The Company improperly presented loan costs related to the convertible debt as a reduction of the convertible debt, net of discounts and reclassified these to loan acquisition costs which was $145,821 as of December31, 2010. The Company was separately presenting the fair value of stock warrants issued on the statement of stockholders’ deficit which has been reclassified to additional paid-in capital. The Company improperly presented depreciation and amortization as other income (expense) which has been reclassified to operating expenses and increased the operating loss.

 

The impact of the above adjustments and reclassifications as of December 31, 2010 and for the year ended December 31, 2010 and the three months ended March 31, 2010, three and six months ended June 30, 2010 and three and nine months ended September 30, 2010 is set forth below:

3
 

 

 

Balance Sheets as of December 31, 2010 and September 30, 2010 (Unaudited),

June 30, 2010 (Unaudited), and March 31, 2010 (Unaudited)

 

                 
   As Previously             
   Reported   Adjustments   Reclassifications   As Restated 
Accounts Receivable                    
As of December 31, 2010  $404,624   $   $(99,000)  $305,624 
As of September 30, 2010   364,971        (99,000)   265,971 
As of June 30, 2010   439,600        (99,000)   340,600 
As of March 31, 2010   511,961        (99,000)   412,961 
Prepaid Expenses                    
As of December 31, 2010   209,801    (95,742)   (27,504)   86,555 
As of September 30, 2010   224,120    (57,500)   (47,175)   119,445 
As of June 30, 2010   138,546    (52,500)   (250)   85,796 
As of March 31, 2010   132,482    (45,000)   (14,582)   72,900 
Total Current Assets                    
As of December 31, 2010   1,267,420    (95,742)   (126,504)   1,045,174 
As of September 30, 2010   1,226,638    (57,500)   (146,175)   1,022,963 
As of June 30, 2010   1,310,623    (52,500)   (99,250)   1,158,873 
As of March 31, 2010   1,255,745    (45,000)   (113,582)   1,097,163 
Property & Equipment                    
As of December 31, 2010   205,163    51,000        256,163 
As of September 30, 2010   231,498    56,000        287,498 
As of June 30, 2010   263,138    61,000        324,138 
As of March 31, 2010   295,065    66,000        361,065 
Intangible Assets                    
As of December 31, 2010   279,160    (38,474)       240,686 
As of September 30, 2010   278,179    (23,084)       255,095 
As of June 30, 2010   284,749    (28,386)       256,363 
As of March 31, 2010   272,569    (33,689)       238,880 
Loan Costs, net of amortization                    
As of December 31, 2010           145,820    145,820 
As of September 30, 2010           155,630    155,630 
As of June 30, 2010           165,218    165,218 
As of March 31, 2010           174,588    174,588 
Total Assets                    
   As of December 31, 2010   1,785,185    (83,216)   19,316    1,721,285 
As of September 30, 2010   1,736,315    (24,584)   9,455    1,721,186 
As of June 30, 2010   1,858,510    (19,886)   65,968    1,904,592 
As of March 31, 2010   1,823,379    (12,689)   61,006    1,871,696 

 

 

4
 

   As Previously
Reported
   Adjustments   Reclassifications   As Restated 
Accounts payable and accrued expenses, excluding deferred compensation               
As of December 31, 2010   1,231,240    55,032        1,286,272 
Deferred Revenue                    
As of December 31, 2010   254,667        (99,000)   155,667 
As of September 30, 2010   303,044        (99,000)   204,044 
As of June 30, 2010   293,744        (99,000)   194,744 
As of March 31, 2010   312,005        (99,000)   213,005 
Total Current Liabilities                    
As of December 31, 2010   1,731,251    55,032    (126,504)   1,659,779 
As of September 30, 2010   1,817,414        (146,175)   1,671,239 
As of June 30, 2010   1,676,308        (99,250)   1,577,058 
As of March 31, 2010   1,921,914        (113,582)   1,808,332 
Convertible debt, net of discounts                    
As of December 31, 2010   951,503    (245,958)   145,820    851,365 
As of September 30, 2010   937,070    (268,150)   155,630    824,550 
As of June 30, 2010   922,574    (289,452)   165,218    798,340 
As of March 31, 2010   908,017    (309,879)   174,588    772,726 
Total Liabilities                    
As of December 31, 2010   2,682,754    (190,926)   19,316    2,511,144 
As of September 30, 2010   2,754,484    (268,150)   9,455    2,495,789 
As of June 30, 2010   2,598,882    (289,452)   65,968    2,375,398 
As of March 31, 2010   2,829,931    (309,879)   61,006    2,581,058 
Additional paid-in capital                    
As of December 31, 2010   14,863,493    389,192    3,686,077    18,938,762 
As of September 30, 2010   14,356,893    389,192    3,725,577    18,471,662 
As of June 30, 2010   14,059,765    389,192    3,466,136    17,915,093 
As of March 31, 2010   13,019,251    389,192    3,834,202    17,242,645 
Stock Warrants                    
As of December 31, 2010   3,686,077        (3,686,077)    
As of September 30, 2010   3,725,577        (3,725,577)    
As of June 30, 2010   3,466,136        (3,466,136)    
As of March 31, 2010   3,834,202        (3,834,202)    
Total stockholders' deficit                    
As of December 31, 2010   (897,568)   107,708        (789,860)
As of September 30, 2010   (1,018,169)   242,653        (775,516)
As of June 30, 2010   (740,352)   266,792        (473,560)
As of March 31, 2010   (1,006,552)   281,491        (725,061)

 

 

 

5
 

Statements of Operations

Year Ended December 31, 2010,

Three and Nine months ended September 30, 2010 (Unaudited)

Three and Six Months Ended June 30, 2010 (Unaudited), and

March 31, 2010 (Unaudited)

 

   As Previously             
   Reported   Adjustments   Reclassifications   As Restated 
                     
Depreciation and amortization                    
For Year ended December 31, 2010  $126,683   $33,783   $   $160,466 
For three months ended September 30, 2010   38,179    8,698        46,877 
For nine months ended September 30, 2010   116,641    8,093        124,734 
 
Operating Loss
                    
For Year ended December 31, 2010   (2,169,898)   (104,558)   (128,288)   (2,402,744)
For three months ended September 30, 2010   (822,970)   (8,698)   (38,743)   (870,411)
For nine months ended September 30, 2010   (1,761,970)   (8,092)   (116,038)   (1,886,101)
For three months ended June 30, 2010   (494,358)   303    (39,011)   (533,066)
For six months ended June 30, 2010   (939,000)   606    (77,304)   (1,015,699)
For three months ended March 31, 2010   (446,642)   303    (38,293)   (484,632)
                     
Interest Expense                    
For Year ended December 31, 2010   150,094    83,491        233,585 
For three months ended September 30, 2010   36,032    15,441        51,473 
For nine months ended September 30, 2010   110,565    45,011        155,576 
For three months ended June 30, 2010   38,212    15,002        53,214 
For six months ended June 30, 2010   74,533    29,570        104,103 
For three months ended March 31, 2010   36,321    14,570        50891 
                     
Net Loss                    
For Year ended December 31, 2010   (2,446,675)   (188,049)       (2,634,724)
For three months ended September 30, 2010   (897,181)   (24,138)       (921,319)
For nine months ended September 30, 2010   (1,987,176)   (53,104)       (2,040,280)
For three months ended June 30, 2010   (571,068)   (14,699)       (585,767)
For six months ended June 30, 2010   (1,089,995)   (28,966)       (1,118,961)
For three months ended March 31, 2010   (518,927)   (14,267)       (533,194)
                     
Earnings per share                    
For Year ended December 31, 2010   (0.02)           (0.02)
For three months ended September 30, 2010   (0.01)           (0.01)
For nine months ended September 30, 2010   (0.02)           (0.02)
For three months ended June 30, 2010   (0.00)           (0.00)
For six months ended June 30, 2010   (.0.01)           (0.01)
For three months ended March 31, 2010   (0.00)           (0.00)

6
 

The restatement adjustments and reclassifications as discussed above related to 2010 amounts also had an impact on the previously reported quarterly results for 2011 as follows:

 

Balance Sheets as of September 30, 2011, June 30, 2011 and March 31, 2011 (Unaudited)

 

   As Previously   Beginning Balance             
   Reported   Restatement   Adjustments   Reclassifications   As Restated 
Accounts Receivable                         
As of September 30, 2011  $373,092   $-   $-   $(99,000)  $274,092 
As of June 30, 2011   363,366    -    -    (99,000)   264,366 
As of March 31,2011   397,220    -    -    (99,000)   298,220 
                          
Prepaid Expenses                         
As of September 30, 2011   411,469    -    -    (50,813)   360,656 
As of June 30, 2011   291,126    -    -    (1,562)   289,564 
As of March 31,2011   261,329    -    -    (12,414)   248,915 
                          
Total Current Assets                         
As of September 30, 2011   1,710,488    -    -    (149,813)   1,560,675 
As of June 30, 2011   1,403,834    -    -    (100,562)   1,303,272 
As of March 31,2011   1,224,014    -    -    (111,414)   1,112,600 
                          
Property & Equipment                         
As of September 30, 2011   160,215    -    36,000    -    196,215 
As of June 30, 2011   147,162    -    41,000    -    188,162 
As of March 31,2011   175,383    -    46,000    -    221,383 
                          
Intangible Assets                         
As of September 30, 2011   257,220    -    (34,291)   -    222,929 
As of June 30, 2011   264,533    -    (36,382)   -    228,151 
As of March 31,2011   271,846    -    (37,427)   -    234,419 

 

 

7
 

 

 

 

   As Previously   Beginning Balance             
   Reported   Restatement   Adjustments   Reclassifications   As Restated 
Loan Costs, net of amortization                         
As of September 30, 2011   -    145,820    (20,784)   -    125,036 
As of June 30, 2011   -    145,820    (13,589)   -    132,231 
As of March 31,2011   -    145,820    (6,717)   -    139,103 
                          
Total Assets                         
As of September 30, 2011   2,130,036    145,820    (19,075)   (149,813)   2,106.968 
As of June 30, 2011   1,817,642    145,820    (8,971)   (100,562)   1,853,929 
As of March 31,2011   1,673,784    145,820    1,857    (111,414)   1,710,047 
    -                     
Current maturity of long-term debt                         
As of September 30, 2011   50,813    -    -    (50,813)   - 
As of June 30, 2011   1,562    -    -    (1,562)   - 
As of March 31,2011   12,414    -    -    (12,414)   - 
                          
Deferred Revenue                       - 
As of September 30, 2011   233,534    -    -    (99,000)   134,534 
As of June 30, 2011   213,528    -    -    (99,000)   114,528 
As of March 31,2011   275,341    -    -    (99,000)   176,341 
                          
Total Current Liabilities                         
As of September 30, 2011   1,675,219    -    -    (149,813)   1,525,406 
As of June 30, 2011   1,736,167    -    -    (100,562)   1,635,605 
As of March 31,2011   1,641,625    -    -    (111,414)   1,530,211 

 

 

8
 

 

 

 

   As Previously   Beginning Balance             
   Reported   Restatement   Adjustments   Reclassifications   As Restated 
Convertible debt, net of discounts                         
As of September 30, 2011   993,561    (100,138)   42,179    -    935,602 
As of June 30, 2011   979,595    (100,138)   27,420    -    906,877 
As of March 31,2011   965,576    (100,138)   13,365    -    878,803 
                          
Total Liabilities                         
As of September 30, 2011   2,668,780    (100,138)   42,179    (149,813)   2,461,008 
As of June 30, 2011   2,715,762    (100,138)   27,420    (100,562)   2,542,482 
As of March 31,2011   2,607,201    (100,138)   13,365    (111,414)   2,409,014 
                          
Additional paid-in capital                         
As of September 30, 2011   16,682,782    -    -    4,047,387    20,730,169 
As of June 30, 2011   15,796,437    -    -    3,882,422    19,678,859 
As of March 31,2011   15,188,113    -    -    3,798,467    18,986,580 
                          
Warrants                         
As of September 30, 2011   4,047,387    -    -    (4,047,387)   - 
As of June 30, 2011   3,882,422    -    -    (3,882,422)   - 
As of March 31,2011   3,798,467    -    -    (3,798,467)   - 
                          
Accumulated Deficit                         
As of September 30, 2011   (22,772,857)   (281,484)   (72,956)   -    (23,127,297)
As of June 30, 2011   (21,818,628)   (281,484)   (48,920)   -    (22,149,032)
As of March 31,2011   (20,017,094)   (281,484)   (24,037)   -    (20,322,615)
                          
                          
9
 
   As Previously   Beginning Balance             
   Reported   Restatement   Adjustments   Reclassifications   As Restated 
Total stockholders' deficit                         
As of September 30, 2011   (538,744)   (281,484)   (72,956)   -    (893,184)
As of June 30, 2011   (898,120)   (281,484)   (48,920)   -    (1,228,524)
As of March 31,2011   (933,417)   (281,484)   (24,037)   -    (1,238,938)

 

 

 

10
 

 

Statements of Operations

 

Three and Nine Months ended September 30, 2011 (Unaudited),

 

Three and Six Months ended June 30, 2011(Unaudited), and

 

Three Months ended March 31, 2011 (Unaudited)

 

 

   As Previously             
   Reported   Adjustments   Reclassification   As Restated 
                     
Operating Loss                    
Three Months ended September 30, 2011  $(880,009)  $(3,955)  $(32,874)  $(916,838)
Nine Months ended September 30, 2011   (2,140,892)   (11,86)   (108,242)   (2,261,000)
Three Months ended June 30, 2011   (772,832)   (3,956)   (36,585)   (813,373)
Six Months ended June 30, 2011   (1,210,881)   (7,911)   (75,368)   (1,294,160)
Three Months ended March 31, 2011   (444,642)   (3,955)   (38,783)   (487,380)
                     
Interest Expense                    
Three Months ended September 30, 2011   41,347    20,082    -    61,429 
Nine Months ended September 30, 2011   125,088    61,091    -    186,179 
Three Months ended June 30, 2011   42,116    20,927    -    63,043 
Six Months ended June 30, 2011   83,741    41,009    -    124,750 
Three Months ended March 31, 2011   41,625    20,082    -    61,707 
                     
                     

 

Net Loss

Three Months ended September 30, 2011

   (954,230)   (24,037)   -    (978,267)
Nine Months ended September 30, 2011   (2,090,890)   (72,957)   -    (2,163,847)
Three Months ended June 30, 2011   (801,533)   (24,883)   -    (826,416)
Six Months ended June 30, 2011   (1,369,992)   (48,920)   -    (1,418,912)
Three Months ended March 31, 2011   (568,459)   (24,037)   -    (592,496)
                     
Earnings per share                    
Three Months ended September 30, 2011   (0.01)   (0.00)   -    (0.01)
Nine Months ended September 30, 2011   (0.01)   (0.00)   -    (0.01)
Three Months ended June 30, 2011   (0.01)   (0.00)   -    (0.01)
Six Months ended June 30, 2011   (0.01)   (0.00)   -    (0.01)
Three Months ended March 31, 2011   (0.00)   (0.00)   -    (0.00)

 

 

 

11
 

 

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

 

 

Exhibit Number

Description

 

99.1 Press Release dated May 10, 2012 (incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K filed on May 10, 2012)

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  GeneLink, Inc.
(Registrant)
   
  By:  /s/ Bernard L. Kasten, Jr. M.D.
Dated: May 11, 2012    Bernard L. Kasten, Jr. M.D.
Chief Executive Officer
12